0001209191-23-037350.txt : 20230615 0001209191-23-037350.hdr.sgml : 20230615 20230615162724 ACCESSION NUMBER: 0001209191-23-037350 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230614 FILED AS OF DATE: 20230615 DATE AS OF CHANGE: 20230615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mayweg Alexander CENTRAL INDEX KEY: 0001786260 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40522 FILM NUMBER: 231017722 MAIL ADDRESS: STREET 1: C/O VERSANT VENTURES, AESCHENVORSTADT 36 CITY: BASEL STATE: V8 ZIP: 4051 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Monte Rosa Therapeutics, Inc. CENTRAL INDEX KEY: 0001826457 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 321 HARRISON AVENUE STREET 2: SUITE 900 CITY: BOSTON STATE: MA ZIP: 02118 BUSINESS PHONE: 617-949-2643 MAIL ADDRESS: STREET 1: 321 HARRISON AVENUE STREET 2: SUITE 900 CITY: BOSTON STATE: MA ZIP: 02118 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-14 0 0001826457 Monte Rosa Therapeutics, Inc. GLUE 0001786260 Mayweg Alexander MONTE ROSA THERAPEUTICS, INC. 321 HARRISON AVENUE, SUITE 900 BOSTON MA 02118 1 0 0 0 0 Stock Option (Right to Buy) 6.59 2023-06-14 4 A 0 20500 0.00 A 2033-06-13 Common Stock 20500 20500 D The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 14, 2024 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time. /s/ Ajim Tamboli, Attorney-in-Fact 2023-06-15